Author

B. Lehri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

B. W. Wren· 3 shared F. Nasher· 2 shared R. A. Stabler· 2 shared A. Corser· 1 shared A. Dell· 1 shared E. Atkins· 1 shared E. Bakke· 1 shared E. Kay· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

B. W. Wren

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Understanding Campylobacter coli isolates from the Vietnamese meat production network; a pilot study

B. Lehri, G. Navoly, A. Corser, F. Nasher, S. Willcocks, P. T. Ngoc, B. W. Wren, L. Q. Huong, R. A. Stabler

This study characterizes seven Campylobacter coli strains from Vietnam, revealing high antimicrobial resistance and virulence, and highlights their global spread.

bioRxiv · Nov 10, 2023 · PreprintMicrobiology

Survival of Campylobacter jejuni in Acanthamoebae castellanii provides mechanistic insight into host pathogen interactions.

F. Nasher, B. Lehri, M. F. Horney, R. a. Stabler, B. W. Wren

This study shows that Campylobacter jejuni can survive inside Acanthamoebae castellanii, using similar mechanisms as in warm-blooded hosts, suggesting amoebae as transient hosts for persistence and transmission.

bioRxiv · Jul 26, 2022 · PreprintMicrobiology

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines.

S. Abouelhadid, E. Atkins, E. Kay, I. Passmore, S. J. North, B. Lehri, P. Hitchen, E. Bakke, M. Rahman, J. Bosse, Y. Li, V. S. Terra, P. Langford, A. Dell, B. W. Wren, J. Cuccui

This paper develops a novel glycoengineering platform, MAGIC, which increases glycoconjugate yield and enables vaccine development in genetically intractable bacteria.

bioRxiv · Nov 25, 2021Microbiology